Bill

Bill > HR2064


US HR2064

To amend title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to certain health care providers, and for other purposes.


summary

Introduced
04/03/2019
In Committee
04/04/2019
Crossed Over
Passed
Dead
12/31/2020

Introduced Session

116th Congress

Bill Summary

Requires drug manufacturers to provide the Department of Health and Human Services with aggregate data related to product samples of drugs, devices, biologic products, and medical supplies given to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023.

AI Summary

This bill amends Title XI of the Social Security Act to require manufacturers of certain drugs, devices, biologicals, and medical supplies to report on product samples provided to hospitals, physicians, or other medical professionals during the previous calendar year, beginning in 2023. The bill requires manufacturers to submit aggregate data on the total quantity and value of such product samples provided to covered recipients. This information will then be made publicly available by the Department of Health and Human Services.

Committee Categories

Business and Industry, Health and Social Services

Sponsors (2)

Last Action

Subcommittee Hearings Held. (on 05/21/2019)

bill text


bill summary

Loading...

bill summary

Loading...
Loading...